Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Risa Wakisaka"'
Autor:
Ryosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda, Risa Wakisaka, Takahiro Inoue, Takumi Kumai, Miki Takahara
Publikováno v:
Cancers, Vol 16, Iss 6, p 1205 (2024)
Salivary gland cancer (SGC) is rare and comprises over 20 histological subtypes. Recently, clinical experience regarding immunotherapies for SGCs has been accumulating, yet their efficacy remains controversial. Understanding the tumor microenvironmen
Externí odkaz:
https://doaj.org/article/2da5c7d1fccd4695af7c048e2816f30a
Autor:
Ryosuke Sato, Takumi Kumai, Yoshiya Ishida, Ryota Yuasa, Akinobu Kubota, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Tetsuji Wada, Yasuaki Harabuchi
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 7, Iss 6, Pp 1808-1813 (2022)
Abstract Objective Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the
Externí odkaz:
https://doaj.org/article/ca0a211bf99d4de2a49a0285761b8603
Autor:
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, Ryosuke Sato, Takahiro Inoue, Takumi Kumai, Miki Takahara
Publikováno v:
Vaccines, Vol 12, Iss 1, p 45 (2023)
The incidence of thyroid cancer (TC) has increased over the past 30 years. Although differentiated thyroid cancer (DTC) has a good prognosis in most patients undergoing total thyroidectomy followed by radioiodine therapy (RAI), 5–10% of patients de
Externí odkaz:
https://doaj.org/article/39e1073d566d408eb55a2ccac763f0c8
Autor:
Michihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki, Takumi Kumai, Ryusuke Hayashi, Risa Wakisaka, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Hiroya Kobayashi, Yasuaki Harabuchi
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Fibroblast growth factor receptor 1 (FGFR1) is overexpressed in multiple types of solid tumors, including head and neck squamous cell carcinoma (HNSCC). Being associated with poor prognosis, FGFR1 is a potential therapeutic target for aggressive tumo
Externí odkaz:
https://doaj.org/article/5129a649e75a4c4abc551cc79d5a4892
Autor:
Michihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda, Takumi Kumai, Ryusuke Hayashi, Risa Wakisaka, Ryosuke Sato, Kenzo Ohara, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi
Publikováno v:
Translational Oncology, Vol 18, Iss , Pp 101358- (2022)
Background: A combination therapy with immune checkpoint inhibitors (ICIs) and platinum-based chemotherapy has become the first-line treatment for recurrent or metastatic head and neck squamous carcinoma (HNSCC). Although steroids are often used as a
Externí odkaz:
https://doaj.org/article/529333b2d68c4b60a220081e1e8a78b2
Autor:
Takumi Kumai, Hidekiyo Yamaki, Michihisa Kono, Ryusuke Hayashi, Risa Wakisaka, Hiroki Komatsuda
Publikováno v:
Vaccines, Vol 10, Iss 1, p 70 (2022)
The success of the immune checkpoint blockade has provided a proof of concept that immune cells are capable of attacking tumors in the clinic. However, clinical benefit is only observed in less than 20% of the patients due to the non-specific activat
Externí odkaz:
https://doaj.org/article/7ae34954921f4829be676921f5834906
Autor:
Hiroki Komatsuda, Risa Wakisaka, Michihisa Kono, Takumi Kumai, Ryusuke Hayashi, Hidekiyo Yamaki, Ryosuke Sato, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara, Miki Takahara, Akihiro Katada, Hiroya Kobayashi
Publikováno v:
Cancer Science. 114:399-409
Homeobox B7 (HOXB7) is a master regulatory gene that regulates cell proliferation and activates oncogenic pathways. Overexpression of HOXB7 correlates with aggressive behavior and poor prognosis in patients with cancer. However, the expression and ro
Autor:
Ryosuke Sato, Takumi Kumai, Yoshiya Ishida, Ryota Yuasa, Akinobu Kubota, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Tetsuji Wada, Yasuaki Harabuchi
Publikováno v:
Laryngoscope Investigative Otolaryngology. 7:1808-1813
Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the efficacy and safety
Autor:
Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, Miki Takahara, Kan Kishibe, Shunsuke Yasuda, Yuki Yajima, Akemi Kosaka, Takayuki Ohkuri, Kensuke Oikawa, Shohei Harabuchi, Michihisa Kono, Hidekiyo Yamaki, Risa Wakisaka, Yui Hirata-Nozaki, Kenzo Ohara, Takumi Kumai, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi, Hiroya Kobayashi
Publikováno v:
Cancer Immunology, Immunotherapy.
Autor:
Hidekiyo Yamaki, Michihisa Kono, Risa Wakisaka, Hiroki Komatsuda, Takumi Kumai, Ryusuke Hayashi, Ryosuke Sato, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara, Kan Kishibe, Miki Takahara, Tatsuya Hayashi, Hiroya Kobayashi, Akihiro Katada
Brachyury is a transcription factor belonging to the T-box gene family and is involved in the posterior formation of the mesoderm and differentiation of chordates. As the overexpression of Brachyury is a poor prognostic factor in a variety of cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37964f5c4f4f66e362d61b72b663222
https://doi.org/10.21203/rs.3.rs-2553923/v1
https://doi.org/10.21203/rs.3.rs-2553923/v1